about
Propionyl-L-carnitine for intermittent claudicationMitochondria: a new therapeutic target in chronic kidney diseaseEffective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysisDietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats.Decrease in hyperosmotic stress-induced corneal epithelial cell apoptosis by L-carnitine.Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.Acute management of propionic acidemia.Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasisStructural and biochemical studies of the substrate selectivity of carnitine acetyltransferase.Disposition and metabolite kinetics of oral L-carnitine in humans.L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled studyIn HepG2 cells, coexisting carnitine deficiency masks important indicators of marginal biotin deficiency.Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathyEffects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients.Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer?Effects of acetaldehyde and L-carnitine on morphology and enzyme activity of myocardial mitochondria in rats.A pharmacokinetic model for L-carnitine in patients receiving haemodialysisLevocarnitine and dialysis: a review.The use of carnitine in pediatric nutrition.Does L-carnitine improve endothelial function in hemodialysis patients?L-carnitine preserves endothelial function in a lamb model of increased pulmonary blood flowNatural antioxidants in Alzheimer's disease.Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction.L-carnitine supplementation in the dialysis population: are Australian patients missing out?A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction.Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysisPropionyl l-carnitine: intermittent claudication and peripheral arterial disease.Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients.Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.Intermittent claudication: new targets for drug development.Pharmacologic Treatment of Common Symptoms in Dialysis Patients: A Narrative Review.Five potential therapeutic agents as antidepressants: a brief review and future directions.Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: A cross-sectional study.Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins.Significance of l-carnitine for human health.L-Carnitine ameliorates glycerol-induced myoglobinuric acute renal failure in rats.L-Carnitine Supplementation Improves Self-Rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis.Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil.Increased urinary excretion of carnitine and acylcarnitine by mercuric chloride is reversed by 2,3-dimercapto-1-propanesulfonic acid in rats.
P2860
Q24201080-7F923C7B-9802-44A7-ADBB-E3878B893D73Q26776397-DCB2739B-C407-4247-BBB4-8C43E7A04D29Q27027544-0E03C471-CA8F-4593-88EE-4FCAF0521F07Q30319820-B5D11B96-5FEA-4ED7-8FE2-55818B77EC02Q30448957-F0343738-2438-419E-9D24-2A764FDAD69EQ33749467-71C52A70-8F2E-4DD4-A2BA-24EF81611D24Q34049906-AB87F6EC-42E0-468B-BC77-166FA06E7A19Q34094462-7871A03F-E9CD-4EF5-ACB0-75772FFFDAF9Q34322152-F1DC4DF3-3C3B-4492-8412-CED600743056Q34567517-E09EDFB9-65A2-40BD-AA85-FEBDDB9B506CQ34643225-21431FF1-672D-4393-8044-C02BA470B035Q34684215-7AB5B772-346A-4C58-903A-F975F25D97B8Q35071386-28890565-E349-481C-B2CE-DC80BA7BB1ABQ35232132-DC7BB0B9-61E8-42F7-BCD2-62E5550D7C1BQ35232161-62C4A124-6EC4-41F2-9CE9-9CA21A352E1FQ35236448-CC508FE5-B58C-4654-9ED5-5F70A4930225Q36024680-D8412F34-8E2F-43FB-8509-36DB6A996850Q36278353-EDA1597D-4EFA-4D95-95E8-89FDFF3E2BA6Q36765315-F8BE911B-4425-489C-B325-84D780F7C853Q36789764-9F00041B-C3A1-46B0-AE42-A969B262621FQ37004620-D601CAED-174F-4D08-9C95-12579C917751Q37016092-4BCDFAFF-3D48-435B-9C6C-8892091FB003Q37052474-856AE658-3E87-4F43-B6D3-FA2D1062E240Q37058531-2BB50045-4024-470F-B918-0664B4D8D92EQ37399610-9D54B345-D03C-4C4E-95E3-C8C50955E87DQ37406686-316FABDC-067A-4B9A-A639-D9549CF8995FQ37614555-1E350FD7-14D2-4BF9-BBA3-205FB2A862FEQ37980384-3A8FC2A3-38A0-4C64-9F6F-998A95B10244Q38026944-5C2886E0-41D0-42FC-98AC-BE4DBD79E29BQ38074225-ADE3CBD8-48C9-46D6-BD0E-9B1450214B71Q38115205-94B10DA5-2253-4AB2-B8F3-C7FD0FF86CBAQ38442886-63382E54-C877-4DEA-814C-FAB2B2622BCDQ38574831-596BF7D5-6149-4B36-A896-9631AFDCAA9CQ38879830-FB662ECE-FCB0-44E1-92BF-DCDE20CF6F6FQ39116791-DEAFA76D-9415-4EAF-923F-3FD04AFD3781Q39400152-BB1C83B9-05E9-4053-81B9-864DE0A51D32Q41998212-6C93B39E-69DE-458A-9672-BD8A6C0BCD67Q42204098-4F639728-7C11-49EA-B28E-397CE191AD57Q42283775-17780CFA-AA96-439D-BB12-20F88822F7BBQ43071427-01916E54-7585-47F9-A87C-F8CD8E10FEF3
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacokinetics of L-carnitine.
@ast
Pharmacokinetics of L-carnitine.
@en
Pharmacokinetics of L-carnitine.
@nl
type
label
Pharmacokinetics of L-carnitine.
@ast
Pharmacokinetics of L-carnitine.
@en
Pharmacokinetics of L-carnitine.
@nl
prefLabel
Pharmacokinetics of L-carnitine.
@ast
Pharmacokinetics of L-carnitine.
@en
Pharmacokinetics of L-carnitine.
@nl
P1476
Pharmacokinetics of L-carnitine.
@en
P2093
Allan M Evans
Gianfranco Fornasini
P304
P356
10.2165/00003088-200342110-00002
P577
2003-01-01T00:00:00Z
P6179
1007359994